Quality Management
Taj Oncology's quality management system includes all aspects of quality relating to facilities, products, and service. However, quality management is not only focused on product and service quality, but also the means to achieve it. Quality management therefore uses quality assurance and control of processes as well as products to achieve the most consistent quality possible.
The Taj Oncology philosophy on quality management focuses on establishing quality, productivity, and a competitive position. Our management are evaluated monthly on the following principals:
Customer Focus
Understanding current and future customer needs is paramount to our success. It is our policy to meet customer requirements and exceed the expectations of all customers.
Leadership
Our management establishes a system of accountability in which every employee assumes a leadership role, resulting in every member of every department becoming fully involved in achieving quality objectives.
Process Approach
Every task, activity, and resource must follow established procedures to ensure uniformity and accountability in everything we do.
Continual Improvement
One of our permanent quality objectives is the continual improvement of overall performance, which is implemented and evaluated on an individual level. Every employee is expected to also contribute to the improvement of the company as a whole.
Factual Decision making Processes
All decisions made by management are based on data analysis and information. Decisions to be made without such required information must get approval of our Board.
Taj Pharma Group
A dream for new world Anchored in India and committed to its traditional values of leadership with trust, the Taj Pharma Group is spreading its footprint globally through excellence and innovation.
Each operating company in the group develops its international business as an integral element in an overall strategy, depending on the competitive dynamics of the industry in which it operates. For some businesses a focus on the export market remains the priority. For others it is developing a robust presence in domestic markets given growing population of India. And then there are Group companies, a small but growing number, that have global ambitions; additionally, synchronizing these ventures to cater Indian market remains a priority for growth.
Exports from India remain the cornerstone of the Taj Pharma Group’s international business, but different Taj companies are increasingly investing in assets overseas through Greenfield projects (such as in Spain, Germany, Middle East, Africa, Russia, and CIS Countries), joint ventures (in Sri Lanka, UK) and acquisitions.
While individual Taj companies have differing geographical imperatives, the Taj group is focusing on a clutch of priority countries, which are expected to be of strategic importance in the years ahead. The regions are UK, Sri Lanka, the Netherlands, Germany, South Africa, members of the Gulf Cooperation Council, Brazil, Vietnam, Thailand and Taiwan.
Dr. R.K.Singh, Chairman, Taj Pharmaceuticals Limited., sums up the Taj group’s efforts to internationalize its operations thus: “We hope that a several years from now we will spread our wings far beyond India, that we become a global group, operating in many countries, an Indian business conglomerate that is at home in the world, carrying the same sense of trust that we do today." We have already progressed on such efforts by our current presence in more than 40 countries.
